
Giredestrant-Everolimus Doubles Survival in ESR1-Mutated Breast Cancer
The evERA trial shows the all-oral combination of giredestrant and everolimus significantly improves progression-free survival for patients with advanced breast cancer.
Every Womens Health story tagged Cycle.

The evERA trial shows the all-oral combination of giredestrant and everolimus significantly improves progression-free survival for patients with advanced breast cancer.

A new NHS genomic test can diagnose brain tumour type in under two hours during surgery, replacing waits of up to eight weeks.

A survey by the Alzheimer's Society reveals hundreds of families wait months or years for a dementia diagnosis.

A large study found embryos with whole chromosome abnormalities resulted in zero live births.

A 43-year-old woman with a high breast cancer risk was billed $1,191.10 for a preventive MRI, despite pre-approval.

Abortion providers report more later-term procedures as state bans spread and insurance access declines, creating major financial and logistical barriers.
NHS England will offer at-home HPV self-collection kits to 4 million women aged 30-65 who have missed NHS cervical screening appointments, aiming to boost participation and move toward eliminating cervical cancer by 2040.

GLP-1 drugs show promise in treating polyendocrine metabolic ovarian syndrome.